Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 22 February

Paulina Peters
February 22, 2022

Morning Bell 21 February

Sophia Mavridis
February 21, 2022

Weekly Wrap 18 February

Sophia Mavridis
February 18, 2022

Morning Bell 17 February

Paulina Peters
February 17, 2022

Morning Bell 16 February

Sophia Mavridis
February 16, 2022

Morning Bell 15 February

Paulina Peters
February 15, 2022

Morning Bell 14 February

Sophia Mavridis
February 14, 2022

Weekly Wrap 11 February

Sophia Mavridis
February 11, 2022

Morning Bell 10 February

Paulina Peters
February 10, 2022

Morning Bell 9 February

Sophia Mavridis
February 9, 2022

Morning Bell 8 February

Paulina Peters
February 8, 2022

Morning Bell 7 February

Sophia Mavridis
February 7, 2022